A reduction of the levels of ANPEP in HGPS would be responsible for the inhibition of PRPS1 through amino-acid starvation and, even more importantly, would contribute to the hypertension and high blood pressure levels that, long term, derive in the cardiovascular malfunction characteristic of the disease. The gene discussed is PRPS1; the disease is hypertensive disorder.